Outlook Therapeutics Inc. Revenue 2015–2025
Outlook Therapeutics Inc. annual/quarterly revenue history and growth rate from 2015 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Outlook Therapeutics Inc. revenue for the quarter ending June 30, 2025 was 1.5 M, a 157.83% increase year-over-year.
- Outlook Therapeutics Inc. revenue for the twelve months ending June 30, 2025 was 3.8 M, a 45.02% increase year-over-year.
- Outlook Therapeutics Inc. annual revenue for 2025 was 1.4 M, a 82.65% decrease from 2019.
- Outlook Therapeutics Inc. annual revenue for 2019 was 8.1 M, a 163.84% increase from 2018.
- Outlook Therapeutics Inc. annual revenue for 2018 was 3.1 M, a 18.99% decrease from 2017.
- Outlook Therapeutics Inc. annual revenue for 2017 was 3.8 M.
Outlook Therapeutics Inc. (OTLK) — Frequently Asked Questions
Outlook Therapeutics Inc. (OTLK) is a publicly traded US company. It has a market capitalization of $31M. In fiscal 2025 it reported revenue of $1M and net income of -$62M. Explore OTLK's stock price, financial statements, earnings history, margins and key ratios below.
What is Outlook Therapeutics Inc.'s market cap?
Outlook Therapeutics Inc. (OTLK) has a market capitalization of $31M.
What is the OTLK stock price?
OTLK trades at $0.89 (+26.24% on the day).
How much revenue does Outlook Therapeutics Inc. make?
Outlook Therapeutics Inc. reported revenue of $1M in fiscal 2025.
Is OTLK profitable?
In fiscal 2025, Outlook Therapeutics Inc. reported net income of -$62M.